Comparison of different anti-vascular endothelial growth factors for the treatment of wet age-related macular degeneration

Project: Research

Description

To compare the development of patients with wAMD treated with aflibercept (Eylea) or ranibizumab (Lucentis) or bevacizumab (Avastin): which patient groups achieve best visual acuity? Is any difference between patients who receive a certain medication compared to others?
Short titleForskning om gula fläcken
StatusActive
Effective start/end date2015/01/01 → …

Collaborative partners

Participants